Arca
Skip to content

Dimension Vista Flex Reagent Cartridges

Colorimetry, Acetaminophen. 510(k) K061655, from Dade Behring, Inc. (Newark, DE). Product code LDP, class 2.

As of Nov 18, 2026, K061655 is an FDA 510(k) held by Dade Behring, Inc., substantially equivalent on Jul 10, 2006 after 27 days, with 7 recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jul 10, 2006
  • Review time: 27 days
  • Recalls: 7
  • Cited as a predicate by: 1 device

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Dimension Vista™ Acetaminophen (ACTM) Flex® reagent cartridge is a device intended to measure acetaminophen, an analgesic and antipyretic (fever reducing) drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of acetaminophen overdose.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

1 later 510(k) summary names this device as a predicate

Recalls

Recalls FDA ties to K061655, newest first; each opens FDA's recall record
Jun 29, 2017Z-1660-2018Various assays used to measure different chemical levels in blood, urine, or cerebrospinal fluid may interfere with the drugs sulfasalazine and/or sulfapyridine causing falsely elevated or falsely depressed results.Terminated
Jun 29, 2017Z-1658-2018Various assays used to measure different chemical levels in blood, urine, or cerebrospinal fluid may interfere with the drugs sulfasalazine and/or sulfapyridine causing falsely elevated or falsely depressed results.Terminated
Mar 17, 2016Z-1665-2016Siemens Healthcare Diagnostics has become aware of N-Acetylcysteine (NAC) and Metamizole (Dipyrone) interference with Trinder and Trinder-like reaction assays. Siemens has confirmed that falsely depressed results may…Terminated
Mar 17, 2016Z-1666-2016Siemens Healthcare Diagnostics has become aware of N-Acetylcysteine (NAC) and Metamizole (Dipyrone) interference with Trinder and Trinder-like reaction assays. Siemens has confirmed that falsely depressed results may…Terminated
Sep 30, 2015Z-0339-2016Erroneous low results on a small number of reagent wells. There is the potential for under-recovery on certain wells for quality control (QC) and patient sample results. The under-recovery ranged from -0.3 mg/dL [0.12…Terminated
Jul 17, 2012Z-2175-2012Siemens has received complaints of customers experiencing slopes >1.05 when calibrating Flex(R) reagent cartridge lot 12095AD. This results in a slope failure and prevents the VANC assay from being run on the Dimension…Terminated
Feb 17, 2012Z-1433-2012Firm has confirmed a negative shift of approximately 0.2mg/dL [0.08 mmol/L] in patient and QC samples when using Vista MagnesiumTerminated

Other LDP Clearances

The newest 510(k)s for the same product code; see every LDP device

Record

Type
Special
Received
Jun 13, 2006
Review panel
Clinical Toxicology
Regulation
21 CFR 862.3030

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.